Millions of people live for years with chronic digestive symptoms — bloating, persistent diarrhea, fatigue, unexplained weight loss — without ever receiving a diagnosis that explains them. A report from DW examines why that gap remains so large. For celiac disease, the answer is more complicated — and more preventable — than most people realize.
What This Means for You
For celiac patients and their families, the diagnostic delay is not a surprise. It is a reality. The average time between a celiac patient’s first symptoms and an actual diagnosis is still measured in years, not weeks. During that window, intestinal damage accumulates, nutritional deficiencies deepen, and quality of life erodes. For a child, undiagnosed celiac disease can affect growth, development, and bone density during years when those things matter most.
As a celiac parent, I know how disorienting this disease can be before you have a name for it. Raising my son has taught me that celiac hides in plain sight — presenting as symptoms that look like something else, tests that come back in the normal range, and a trail of appointments that leads nowhere for too long. Research we’ve covered previously suggests that as many as 83–85% of Americans with celiac have never been diagnosed at all. The DW report makes clear this is not uniquely American: it is a global pattern.
Three factors drive most of this diagnostic failure. First, celiac does not look like one disease. Patients may come in with classic GI symptoms, or with anemia, infertility, bone loss, neurological problems, or no obvious symptoms at all. A clinician who has only seen textbook presentations may not think to test. Second, irritable bowel syndrome (IBS) is diagnosed from symptoms alone with no specific test required — and many patients who fit that profile are never screened further. Studies estimate that a meaningful portion of people diagnosed with IBS have undetected celiac disease. Third, and most preventably: patients who reduce their gluten intake before testing suppress the antibody markers that blood tests detect. They test negative and get sent home.
These are systemic failures, not personal ones. Knowing where the system breaks down is the first step toward working around it.
Key Takeaways
- The average time from first celiac symptoms to diagnosis remains 6–10 years in many countries
- Celiac presents differently in different people — digestive symptoms are only one possibility
- IBS is the most common initial misdiagnosis for celiac patients
- Eating gluten-free before testing can produce a false-negative blood result — patients must stay on a normal gluten-containing diet until testing is complete
- First-degree relatives of celiac patients carry roughly a 1-in-10 lifetime risk and should be screened even without symptoms
The Science
Want to understand how this actually works? We’ll walk you through the technical details below and define every term. No medical degree required.
Why Blood Tests Can Miss Celiac
The standard celiac screening panel tests for anti-tissue transglutaminase IgA antibodies (abbreviated tTG-IgA) — proteins the immune system produces when it reacts to gluten in a celiac patient. These antibodies are reliable markers of active disease, but only when a patient is actually eating gluten.
If someone has already reduced gluten intake — even partially — antibody levels can drop below detectable thresholds. The test returns negative. The patient is told celiac is unlikely. They may go gluten-free anyway but without a formal diagnosis, losing access to follow-up monitoring, nutritional support, and the clear medical record that matters if complications develop later.
A second complication: roughly 2–3% of celiac patients have selective IgA deficiency, meaning their bodies produce very little of the immunoglobulin A class of antibody. For these patients, a standard tTG-IgA test will return negative regardless of gluten intake. These cases require alternative testing using IgG-based markers such as deamidated gliadin peptide IgG (DGP-IgG) — a test that is not always ordered on a first pass.
The Seronegative Problem
Seronegative celiac disease refers to patients who have confirmed intestinal damage from celiac disease — visible under biopsy — but who test negative on standard blood panels. Estimates vary across studies, but seronegative cases may account for 6–9% of celiac diagnoses. These patients are especially vulnerable to being dismissed: even a clinician who orders blood work may stop investigating when the result comes back negative.
Diagnosing seronegative celiac requires an intestinal biopsy — tissue samples taken from the lining of the small intestine during an upper endoscopy. A gastroenterologist (digestive disease specialist) examines those samples under a microscope for villous atrophy — the flattening of the small, finger-like projections called villi that line the intestinal wall and handle nutrient absorption. Villous atrophy is the defining feature of active celiac disease.
Why Symptom Variability Creates Diagnostic Dead Ends
Celiac disease triggers an immune response to gluten — a protein in wheat, barley, and rye — that damages the small intestine. The downstream symptoms depend on which specific nutrient deficiencies develop and how extensive the intestinal damage becomes.
A patient with significant villous atrophy may experience malabsorption — a failure to absorb nutrients through the damaged intestinal wall — leading to deficiencies in iron, folate, calcium, and vitamin D simultaneously. Each deficiency produces its own set of symptoms: fatigue and anemia from iron loss, bone pain and reduced bone density from calcium and vitamin D loss. This scatter-shot presentation often sends patients to multiple specialists — a hematologist for anemia, a rheumatologist for joint pain, an endocrinologist for bone density — before anyone ties the symptoms to a single root cause.
The patients with mild or no GI symptoms face the steepest climb. Silent celiac disease — documented intestinal damage with few or no noticeable symptoms — is real. These patients may feel well enough that neither they nor their doctors pursue further investigation. Yet the damage accumulates regardless of how the patient feels day-to-day.
The Family Risk Factor
Celiac disease is strongly genetic. Nearly all patients carry one or both of two HLA gene variants: HLA-DQ2 and HLA-DQ8. Carrying these variants does not guarantee celiac will develop, but not carrying them makes celiac disease extremely unlikely.
This genetic link has a direct practical implication: first-degree relatives — parents, siblings, and children of celiac patients — carry roughly a 10% lifetime risk of developing the disease themselves. That is approximately ten times the general population risk, which the latest prevalence data puts at around 1%.
Current clinical guidelines recommend screening first-degree relatives even when they report no symptoms, specifically because silent celiac disease means symptoms are not a reliable indicator of whether damage is occurring. For celiac families, this is a practical action item: if one person in the family has the diagnosis, the rest of the family should be tested.
For anyone who has spent years cycling through appointments without answers, or for parents who suspect something is wrong and keep being told everything looks normal — the DW report validates what the data has shown for years. The system is not built to find celiac efficiently. Knowing its failure points gives patients and families a fighting chance at getting there anyway.
If someone in your family has unexplained digestive problems, chronic fatigue, anemia, or bone issues without a clear cause, ask specifically about celiac testing — and stay on a normal gluten-containing diet until all testing is complete. If a celiac diagnosis already exists in your family, get first-degree relatives screened before symptoms appear.
Nobody should spend a decade being sick before getting an answer. The path there is faster when you know where the gaps are.
Related Coverage
- Could Up to 85% of Americans With Celiac Disease Still Be Undiagnosed?
- How Common Is Celiac Disease? What the Major Prevalence Studies Tell Us
References
- DW.com: Why millions suffer digestive problems without a diagnosis (August 24, 2026)